SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-028094
Filing Date
2022-11-28
Accepted
2022-11-28 14:24:55
Documents
13
Period of Report
2022-11-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K inbp20221128_8k.htm   iXBRL 8-K 45509
  Complete submission text file 0001437749-22-028094.txt   166886

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inbp-20221128.xsd EX-101.SCH 3602
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20221128_def.xml EX-101.DEF 10450
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20221128_lab.xml EX-101.LAB 13929
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20221128_pre.xml EX-101.PRE 10441
7 EXTRACTED XBRL INSTANCE DOCUMENT inbp20221128_8k_htm.xml XML 2314
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31668 | Film No.: 221423822
SIC: 2834 Pharmaceutical Preparations